Dan Shen (salvia Miltiorrhiza) In Medicine: Volume 2. Pharmacology And Quality Control
by Xijun Yan /
2014 / English / PDF
16 MB Download
This book reviews research on Dan Shen, compiles data from
clinical trials and biological experiments, and summarizes the
latest research advances. It covers the medicinal herb, herbal
pieces, and new proprietary drugs that contain it; it also covers
simple and compound, traditional and contemporary formulas, and
addresses a broad range of subjects, including: standardized
cultivation; biodiversity; effective substances and their
biological activities; quality control; and clinical trials. The
book goes on to present the clinical trials on Dantonic,
especially focusing on its therapeutic effects for coronary heart
disease. It discusses compound prescriptions and compatibilities,
from the herbal piece level to composition level, and describes
approaches to research on modern Chinese medicine.
This book reviews research on Dan Shen, compiles data from
clinical trials and biological experiments, and summarizes the
latest research advances. It covers the medicinal herb, herbal
pieces, and new proprietary drugs that contain it; it also covers
simple and compound, traditional and contemporary formulas, and
addresses a broad range of subjects, including: standardized
cultivation; biodiversity; effective substances and their
biological activities; quality control; and clinical trials. The
book goes on to present the clinical trials on Dantonic,
especially focusing on its therapeutic effects for coronary heart
disease. It discusses compound prescriptions and compatibilities,
from the herbal piece level to composition level, and describes
approaches to research on modern Chinese medicine.Volume 1 describes the biology and chemistry of Dan Shen, while
Volume 2 focuses on pharmacology and quality control. Volume 3
describes the clinical research on Dan Shen.
Volume 1 describes the biology and chemistry of Dan Shen, while
Volume 2 focuses on pharmacology and quality control. Volume 3
describes the clinical research on Dan Shen.
Editor Xijun Yan is the President of Tianjin Tasly Group and a
Member of the TCM Standardization Technical Committee. Gathering
contributions from more than 100 authors working in the field of
pharmaceutical and clinical research, the book presents and
analyzes the available information from multiple aspects,
reflects the current status of Dan Shen research, and offers an
essential reference work for further research and development.
Editor Xijun Yan is the President of Tianjin Tasly Group and a
Member of the TCM Standardization Technical Committee. Gathering
contributions from more than 100 authors working in the field of
pharmaceutical and clinical research, the book presents and
analyzes the available information from multiple aspects,
reflects the current status of Dan Shen research, and offers an
essential reference work for further research and development.